Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teusink, B.
Right arrow Articles by Havekes, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teusink, B.
Right arrow Articles by Havekes, L. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:614-620, 2003
© 2003 by the American Diabetes Association, Inc.

Contribution of Fatty Acids Released From Lipolysis of Plasma Triglycerides to Total Plasma Fatty Acid Flux and Tissue-Specific Fatty Acid Uptake

Bas Teusink1, Peter J. Voshol1,2, Vivian E.H. Dahlmans1, Patrick C.N. Rensen1,3, Hanno Pijl2, Johannes A. Romijn2, and Louis M. Havekes1,3

1 TNO Prevention and Health, Gaubius Laboratory, Leiden, the Netherlands
2 Department of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands
3 Department of Cardiology and Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands

There is controversy over the extent to which fatty acids (FAs) derived from plasma free FAs (FFAs) or from hydrolysis of plasma triglycerides (TGFAs) form communal or separate pools and what the contribution of each FA source is to cellular FA metabolism. Chylomicrons and lipid emulsions were labeled with [3H]triolein, injected into mice, and appearance in plasma of [3H]oleic acid was estimated, either through a steady-state approach or by compartmental modeling. [14C]oleic acid was included to trace plasma FFA. Eighty to 90% of triglyceride (TG) label was recovered in plasma, irrespective of tracer method or TG source. The contribution of TG lipolysis to total plasma FA turnover was 10–20%. After infusion of [3H]TG and [14C]FA, the retention of these labels varied substantially among liver, adipose tissue, and skeletal and heart muscle. Retention of TG label changed during fasting in the same direction as lipoprotein lipase (LPL) activity is regulated. We propose a model that reconciles the paradoxical 80–90% loss of TG label into plasma with LPL-directed differential uptake of TGFA in tissues. In this model, TGFAs mix locally at the capillaries with plasma FFAs, where they would lead to an increase in the local FA concentration, and hence, FA uptake. Our data indicate that a distinction between TG-derived FA and plasma FFA cannot be made.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
C. Koutsari, D. A. Dumesic, B. W. Patterson, S. B. Votruba, and M. D. Jensen
Plasma Free Fatty Acid Storage in Subcutaneous and Visceral Adipose Tissue in Postabsorptive Women
Diabetes, May 1, 2008; 57(5): 1186 - 1194.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. S. Kim, G. Kewalramani, P. Puthanveetil, V. Lee, U. Kumar, D. An, A. Abrahani, and B. Rodrigues
Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase Dependent Actin Cytoskeleton Organization
Diabetes, January 1, 2008; 57(1): 64 - 76.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. P.Y. Koonen, R. L. Jacobs, M. Febbraio, M. E. Young, C.-L. M. Soltys, H. Ong, D. E. Vance, and J. R.B. Dyck
Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity
Diabetes, December 1, 2007; 56(12): 2863 - 2871.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. H. Nelson, R. Basu, C. M. Johnson, R. A. Rizza, and J. M. Miles
Splanchnic Spillover of Extracellular Lipase Generated Fatty Acids in Overweight and Obese Humans
Diabetes, December 1, 2007; 56(12): 2878 - 2884.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. J. A. Moen, A. P. Tholens, P. J. Voshol, W. de Haan, L. M. Havekes, P. Gargalovic, A. J. Lusis, K. W. van Dyk, R. R. Frants, M. H. Hofker, et al.
The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides
J. Lipid Res., October 1, 2007; 48(10): 2182 - 2192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Laplante, W. T. Festuccia, G. Soucy, Y. Gelinas, J. Lalonde, and Y. Deshaies
Involvement of adipose tissues in the early hypolipidemic action of PPAR{gamma} agonism in the rat
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1408 - R1417.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Y. Golovko and E. J. Murphy
Uptake and metabolism of plasma-derived erucic acid by rat brain
J. Lipid Res., June 1, 2006; 47(6): 1289 - 1297.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Rhee, H. Ge, W. Yang, M. Fan, C. Handschin, M. Cooper, J. Lin, C. Li, and B. M. Spiegelman
Partnership of PGC-1{alpha} and HNF4{alpha} in the Regulation of Lipoprotein Metabolism
J. Biol. Chem., May 26, 2006; 281(21): 14683 - 14690.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. R. Barrows and E. J. Parks
Contributions of Different Fatty Acid Sources to Very Low-Density Lipoprotein-Triacylglycerol in the Fasted and Fed States
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1446 - 1452.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A.M. den Boer, J. F.P. Berbee, P. Reiss, M. van der Valk, P. J. Voshol, F. Kuipers, L. M. Havekes, P. C.N. Rensen, and J. A. Romijn
Ritonavir Impairs Lipoprotein Lipase-Mediated Lipolysis and Decreases Uptake of Fatty Acids in Adipose Tissue
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 124 - 129.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. R. Barrows, M. T. Timlin, and E. J. Parks
Spillover of Dietary Fatty Acids and Use of Serum Nonesterified Fatty Acids for the Synthesis of VLDL-Triacylglycerol Under Two Different Feeding Regimens
Diabetes, September 1, 2005; 54(9): 2668 - 2673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. An, G. Kewalramani, D. Qi, T. Pulinilkunnil, S. Ghosh, A. Abrahani, R. Wambolt, M. Allard, S. M. Innis, and B. Rodrigues
{beta}-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1120 - E1127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Pillutla, Y. C. Hwang, A. Augustus, M. Yokoyama, H. Yagyu, T. P. Johnston, M. Kaneko, R. Ramasamy, and I. J. Goldberg
Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1229 - E1235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. B. Patrick, J. McHowat, T. A. Rosenberger, S. I. Rapoport, and E. J. Murphy
Arachidonic acid incorporation and turnover is decreased in sympathetically denervated rat heart
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2611 - H2619.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Vikramadithyan, K. Hirata, H. Yagyu, Y. Hu, A. Augustus, S. Homma, and I. J. Goldberg
Peroxisome Proliferator-Activated Receptor Agonists Modulate Heart Function in Transgenic Mice with Lipotoxic Cardiomyopathy
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 586 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. C. Heijboer, E. Donga, P. J. Voshol, Z.-C. Dang, L. M. Havekes, J. A. Romijn, and E. P. M. Corssmit
Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice
J. Lipid Res., March 1, 2005; 46(3): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Duivenvoorden, B. Teusink, P. C. Rensen, J. A. Romijn, L. M. Havekes, and P. J. Voshol
Apolipoprotein C3 Deficiency Results in Diet-Induced Obesity and Aggravated Insulin Resistance in Mice
Diabetes, March 1, 2005; 54(3): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Baar, C. S. Dingfelder, L. A. Smith, D. A. Bernlohr, C. Wu, A. J. Lange, and E. J. Parks
Investigation of in vivo fatty acid metabolism in AFABP/aP2-/- mice
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E187 - E193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. An, T. Pulinilkunnil, D. Qi, S. Ghosh, A. Abrahani, and B. Rodrigues
The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E246 - E253.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Ruge, L. Neuger, V. Sukonina, G. Wu, S. Barath, J. Gupta, B. Frankel, B. Christophersen, K. Nordstoga, T. Olivecrona, et al.
Lipoprotein lipase in the kidney: activity varies widely among animal species
Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1131 - F1139.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Goudriaan, S. M. S. E. Santo, P. J. Voshol, B. Teusink, K. W. van Dijk, B. J. M. van Vlijmen, J. A. Romijn, L. M. Havekes, and P. C. N. Rensen
The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis
J. Lipid Res., August 1, 2004; 45(8): 1475 - 1481.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. M. Miles, Y. S. Park, D. Walewicz, C. Russell-Lopez, S. Windsor, W. L. Isley, S. W. Coppack, and W. S. Harris
Systemic and Forearm Triglyceride Metabolism: Fate of Lipoprotein Lipase-Generated Glycerol and Free Fatty Acids
Diabetes, March 1, 2004; 53(3): 521 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Muurling, A. M. van den Hoek, R. P. Mensink, H. Pijl, J. A. Romijn, L. M. Havekes, and P. J. Voshol
Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance
J. Lipid Res., January 1, 2004; 45(1): 9 - 16.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. J. Voshol, G. Haemmerle, D. M. Ouwens, R. Zimmermann, R. Zechner, B. Teusink, J. A. Maassen, L. M. Havekes, and J. A. Romijn
Increased Hepatic Insulin Sensitivity Together with Decreased Hepatic Triglyceride Stores in Hormone-Sensitive Lipase-Deficient Mice
Endocrinology, August 1, 2003; 144(8): 3456 - 3462.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.